Stifel Reiterates Buy Rating on Silk Road Medical (SILK)

September 26, 2022 8:17 AM EDT Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $48.00 price target on Silk Road Medical (NASDAQ: SILK) following a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login